Pegylated interferon induced interstitial pneumonitis in a patient with hepatitis C infection.
Torres-Macho
J
J
Servicios de Medicina Interna, Hospital Infanta Cristina, Parla, Madrid, Spain. jtorresmacho@gmail.com
Jara-Chinarro
B
B
Suárez-Aliaga
B
B
Gámez-Díez
S
S
García-de-Casasola
G
G
de-Cuenca-Morón
B
B
D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000150:complications / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins; D014057:Tomography, X-Ray Computed
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a